TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1
about
SEI family of nuclear factors regulates p53-dependent transcriptional activationE2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferasesThe DP-1 transcription factor is required for keratinocyte growth and epidermal stratificationSertad1 encodes a novel transcriptional co-activator of SMAD1 in mouse embryonic heartsTranscriptome Profiling of the Virus-Induced Innate Immune Response in Pteropus vampyrus and Its Attenuation by Nipah Virus Interferon Antagonist FunctionsKelch Repeat and BTB Domain Containing Protein 5 (Kbtbd5) Regulates Skeletal Muscle Myogenesis through the E2F1-DP1 ComplexPhosphorylation at Ser473 regulates heterochromatin protein 1 binding and corepressor function of TIF1beta/KAP1.Normal proliferation and tumorigenesis but impaired pancreatic function in mice lacking the cell cycle regulator sei1.PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein.Coordinated expression of cyclin-dependent kinase-4 and its regulators in human oral tumors.Insights into gene expression changes impacting B-cell transformation: cross-species microarray analysis of bovine leukemia virus tax-responsive genes in ovine B cellsp34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN.BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas.The Drosophila gene taranis encodes a novel trithorax group member potentially linked to the cell cycle regulatory apparatus.Regulation of CDK4KIM-1-mediated phagocytosis reduces acute injury to the kidney.Nutrient/serum starvation derived TRIP-Br3 down-regulation accelerates apoptosis by destabilizing XIAP.FH535 inhibited metastasis and growth of pancreatic cancer cells.TARANIS Functions with Cyclin A and Cdk1 in a Novel Arousal Center to Control Sleep in Drosophila.KIM-1-/TIM-1-mediated phagocytosis links ATG5-/ULK1-dependent clearance of apoptotic cells to antigen presentation.Investigating the genetic circuitry of mastermind in Drosophila, a notch signal effector.Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance.YB-1, the E2F pathway, and regulation of tumor cell growth.Control of sleep by a network of cell cycle genes.TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors.The CtBP2 co-repressor is regulated by NADH-dependent dimerization and possesses a novel N-terminal repression domain.Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer.Role of host cell factor-1 in cell cycle regulation.Identification of a HoxA10 activation domain necessary for transcription of the gene encoding beta3 integrin during myeloid differentiation.CRM1-mediated nuclear export is required for 26 S proteasome-dependent degradation of the TRIP-Br2 proto-oncoprotein.Sumoylation of the transcriptional intermediary factor 1beta (TIF1beta), the Co-repressor of the KRAB Multifinger proteins, is required for its transcriptional activity and is modulated by the KRAB domain.Overexpression of SERTAD3, a putative oncogene located within the 19q13 amplicon, induces E2F activity and promotes tumor growth.CDCA4 is an E2F transcription factor family-induced nuclear factor that regulates E2F-dependent transcriptional activation and cell proliferation.Sertad1 plays an essential role in developmental and pathological neuron death.ACF1 improves the effectiveness of nucleosome mobilization by ISWI through PHD-histone contacts.The complex of TRIP-Br1 and XIAP ubiquitinates and degrades multiple adenylyl cyclase isoformsSertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells.CDCA4, a downstream gene of the Nrf2 signaling pathway, regulates cell proliferation and apoptosis in the MCF‑7/ADM human breast cancer cell line.Derailing the UPS of Protein Turnover in Cancer and other Human Diseases
P2860
180071e13aa7920525fa69d6cb803fd1b58bec3f216cae5f9e1124108795cea57789b12a75681dda3f094099355cedfb05baf16d62596ea561d449de4a0a7e95ce33dd6cf24f937121d7fdd0631ba4f9597a874f394a4287ceff2d28a94a9d84cd738750723a10c00c25dd234b6973a2761f99fe219556fa77443ffba8214c56edfd54e5bc20b33e4cb343c7966712b8b45bd07afc2aa9513f2ae55fe32b6f80e1c5020372d778ec58c8089e28751ff820b1c8b3faaa9179f63bc47c25c08f492b36969dca1cee92fd2fe9faaba37b80894761e4b453b6eb2512046c
P248
Q24314613-4BB29392-E280-4C18-BC59-8A1F97BCAC36Q24646412-266190BA-E390-487C-953E-BA1BA6FD0D74Q28512185-27E60C8D-BDF5-4765-9757-EC7C4464E34EQ28594857-8380D79B-B4A0-4E77-93C3-C9AC9F442AE0Q28646920-9D441436-1823-45D0-B894-64BCBA4835CFQ28975623-3486A63C-1D85-4248-8DBF-F69D87050E64Q33347938-1973B801-3791-40D7-8DD9-FA7EBFEE682FQ33525540-210A84F5-7DB0-4F97-A893-0261246C505FQ34186659-4645A03C-A6E8-4FE0-A638-D8E06F24B807Q34280071-4DD6389B-3947-419E-8372-D8A85F945229Q34353406-EF14DFEF-659D-42F3-BB65-16170920E2FDQ34378916-E77B5436-442E-41EF-81A2-9B99261210A0Q34508316-67EF4FBE-83DF-4632-B8CE-2D19BDA3E139Q34614275-1A13E7F7-A558-4FC5-B103-ECDACC0AB7D5Q35147982-DCC9A3C5-221F-49DD-9F0F-C3A407D4915CQ35409103-43293B1B-AA38-43BA-AE9B-34021607426BQ35781341-6C859BB3-B6C1-4FB0-BCCB-3023A041785DQ35846780-CE889120-DBCB-4350-9E70-4874549A0149Q36025953-687483B0-3C94-41F4-9D25-3E0300A2386AQ36148385-4DAB57C6-482F-431A-B68D-1EC909DD0815Q36416146-D083D942-F0AB-4827-8F1E-93573BDADB06Q36594956-EE152705-7E42-4DCD-9E3B-B905CC4E9E56Q36755479-077B06B0-B255-46C2-9473-9F71DF9DF3ACQ36887697-E2B241B3-A54C-40C5-88D3-0C90AFF2687BQ37164834-A9BD8835-F19F-457A-891E-1CE69E2515AEQ37520306-D75F1CC1-8452-4F41-B920-892AB3A0F0CEQ37880852-60C364C5-2E2B-4092-A7CB-8BF4D1C86ECBQ38024616-ADFC9A7B-8EEF-48A4-A2CB-B60C729252EFQ38302657-FC0CAA9F-E52D-41A8-9B71-DA5A23348789Q40006400-9A9A3DCD-BA12-4D5B-93C4-E86143F03D07Q40171341-93BDB3A5-9F93-488F-9BD9-AC28B2B60DCEQ40177755-F0ECB753-48B7-4DFB-A018-3B79A9062296Q40229927-307C9618-9540-4082-AEA7-7D7A046806D1Q40242419-C2653BE0-C4BA-4426-98A0-BD3653D6BA3DQ40251174-ED452352-223A-4131-94DC-3D8808BFAD4FQ40970772-8F052956-B1BF-4B26-BDD3-E32CFA4C4CC7Q47106228-DAC6B95B-9E44-4F49-83AE-6AFE3D4C00E1Q47276356-51966A3E-9980-44C8-883C-22315F170C0FQ58919335-1CADF271-FACB-46D4-9FDF-369E1C05E6A1
P2860
TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
TRIP-Br: a novel family of PHD ...... ptional activity of E2F-1/DP-1
@ast
TRIP-Br: a novel family of PHD ...... ptional activity of E2F-1/DP-1
@en
TRIP-Br: a novel family of PHD ...... ptional activity of E2F-1/DP-1
@en-gb
TRIP-Br: a novel family of PHD ...... ptional activity of E2F-1/DP-1
@nl
type
label
TRIP-Br: a novel family of PHD ...... ptional activity of E2F-1/DP-1
@ast
TRIP-Br: a novel family of PHD ...... ptional activity of E2F-1/DP-1
@en
TRIP-Br: a novel family of PHD ...... ptional activity of E2F-1/DP-1
@en-gb
TRIP-Br: a novel family of PHD ...... ptional activity of E2F-1/DP-1
@nl
prefLabel
TRIP-Br: a novel family of PHD ...... ptional activity of E2F-1/DP-1
@ast
TRIP-Br: a novel family of PHD ...... ptional activity of E2F-1/DP-1
@en
TRIP-Br: a novel family of PHD ...... ptional activity of E2F-1/DP-1
@en-gb
TRIP-Br: a novel family of PHD ...... ptional activity of E2F-1/DP-1
@nl
P2093
P2860
P921
P356
P1433
P1476
TRIP-Br: a novel family of PHD ...... ptional activity of E2F-1/DP-1
@en
P2093
P2860
P304
P356
10.1093/EMBOJ/20.9.2273
P407
P577
2001-05-01T00:00:00Z